Tatva Chintan Pharma Chem Limited · NSE: TATVA · BSE: 543321
Tatva Chintan Pharma Chem
Quarterly results as filed with BSE. Latest: Q2 FY27 (Jul–Sep 2026), filed 19 Oct 2026.
Q2 FY27 · Consolidated
Revenue
217.32₹ Cr
+75.9% vs year ago
Net profit
21.45₹ Cr
+116.3% vs year ago
EPS, basic
9.17₹
+116.3% vs year ago
Net margin
9.9%
+1.8 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | 217.32 | +75.9% | 21.45 | +116.3% | 9.17 | 19 Oct 2026 |
| Q1 FY27Apr–Jun 2026 | 167.06 | +42.9% | 15.98 | +140.3% | 6.83 | 17 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 134.14 | +24.4% | 10.32 | +902.0% | 4.41 | 16 May 2026 |
| Q3 FY26Oct–Dec 2025 | 131.33 | +52.9% | 15.16 | 110x | 6.49 | 21 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 123.52 | +47.9% | 9.92 | Turned profit | 4.24 | 31 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 116.86 | +10.8% | 6.65 | +27.7% | 2.84 | 24 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 107.86 | +9.8% | 1.03 | −89.3% | 0.44 | 02 May 2025 |
| Q3 FY25Oct–Dec 2024 | 85.90 | +2.0% | 0.14 | −96.0% | 0.06 | 29 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 83.49 | −13.6% | (0.66) | Turned loss | (0.29) | 11 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 105.46 | −7.8% | 5.21 | −45.2% | 2.23 | 20 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 98.27 | −21.1% | 9.61 | −43.3% | 4.11 | 11 May 2024 |
| Q3 FY24Oct–Dec 2023 | 84.21 | −30.2% | 3.46 | −70.3% | 1.48 | 24 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 96.67 | +7.3% | 7.78 | +9.4% | 3.43 | 17 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 114.36 | +29.4% | 9.50 | −3.0% | 4.29 | 04 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 124.51 | +26.4% | 16.95 | −3.2% | 7.65 | 08 May 2023 |
| Q3 FY23Oct–Dec 2022 | 120.61 | +15.2% | 11.62 | −49.0% | 5.24 | 25 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 90.09 | −27.1% | 7.11 | −78.1% | 3.21 | 07 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 88.40 | −17.3% | 9.80 | −57.7% | 4.42 | 26 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 98.53 | — | 17.51 | — | 7.90 | 26 Apr 2022 |
| Q3 FY22Oct–Dec 2021 | 104.67 | — | 22.81 | — | 10.29 | 18 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 123.61 | — | 32.41 | — | 15.02 | 25 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 106.83 | — | 23.15 | — | 11.52 | 17 Aug 2021 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | 207.48 | +79.1% | 15.39 | +72.1% | 6.57 | 19 Oct 2026 |
| Q1 FY27Apr–Jun 2026 | 146.70 | +34.4% | 10.45 | +103.5% | 4.47 | 17 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 132.66 | +23.2% | 9.02 | +724.0% | 3.86 | 16 May 2026 |
| Q3 FY26Oct–Dec 2025 | 138.59 | +65.0% | 15.98 | Turned profit | 6.84 | 21 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 115.86 | +43.1% | 8.94 | Turned profit | 3.82 | 31 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 109.18 | +16.4% | 5.13 | +240.4% | 2.19 | 24 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 107.65 | +14.6% | 1.09 | −86.7% | 0.47 | 02 May 2025 |
| Q3 FY25Oct–Dec 2024 | 84.00 | −2.4% | (1.17) | Turned loss | (0.50) | 29 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 80.96 | −12.5% | (1.11) | Turned loss | (0.47) | 11 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 93.81 | −11.6% | 1.51 | −81.7% | 0.64 | 20 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 93.93 | −21.3% | 8.25 | −48.9% | 3.52 | 11 May 2024 |
| Q3 FY24Oct–Dec 2023 | 86.07 | −24.2% | 4.65 | −55.9% | 1.99 | 24 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 92.57 | +10.2% | 8.20 | +56.1% | 3.63 | 17 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 106.11 | +23.3% | 8.25 | −3.0% | 3.72 | 04 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 119.41 | +17.2% | 16.15 | −14.5% | 7.29 | 08 May 2023 |
| Q3 FY23Oct–Dec 2022 | 113.54 | +11.8% | 10.56 | −52.9% | 4.76 | 25 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 84.04 | −28.0% | 5.26 | −82.9% | 2.37 | 07 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 86.06 | −20.1% | 8.50 | −64.5% | 3.83 | 26 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 101.88 | — | 18.89 | — | 8.52 | 26 Apr 2022 |
| Q3 FY22Oct–Dec 2021 | 101.59 | — | 22.43 | — | 10.12 | 18 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 116.69 | — | 30.72 | — | 14.24 | 25 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 107.65 | — | 23.96 | — | 11.93 | 17 Aug 2021 |
44 filings on record for this company.